Supply Chain

The past few years have highlighted serious deficiencies in prevalent supply chain strategies and the major risk that disruptions pose to corporate success. Loss of sales and market share are the most visible and measurable impacts. McKinsey estimates that shocks lasting a month or longer are occurring every 3.7 years and companies can expect to lose 42% of one year’s EBITDA every decade due to supply chain disruptions.

Professor Sang Kim and President Salovey discuss global supply chain challenges and possible solutions.

Pfizer’s and Moderna’s bivalent boosters, which are now available to many age groups, offer protection against the original COVID-19 virus plus the BA.4 and BA.5 omicron subvariants. Is the nation ready for yet another COVID-19 vaccine shot?

Join NC State University Industry Expansion Solutions (IES) on September 27th at 11:00 a.m. for the Navigating Supply Chain Challenges webinar where Rob Handfield will share knowledge about how manufacturers can navigate current supply chain challenges.

Since its inaugural event, we have been known to say of Digital Procurement World that it is “The Best New Procurement Event in Years.” We made this statement based on its ability to “bring together not only procurement organizations and technology (and services) firms in a conversation around digital, but also to engage the start-up community and investors … and do a great job of connecting them with buyers, consultants and others.”

Using artificial intelligence (AI) in the medical supply chain is a hot topic. But is AI just wishful thinking, or can it really fix supply chain woes— especially those that emerged during the pandemic?

The next person who fills your prescription might not be a person at all. Walgreens recently opened its fourth microfulfillment center since last year. Prescriptions are filled at a warehouse using automation, then brought to the pharmacy for you to pick up.

With the annual peak of hurricane season just two weeks away, JEA says it’s ready for whatever may come, despite supply chain issues that are plaguing the industry and stalling utilities’ efforts to address climate change.

The United Kingdom has become the first nation to conditionally approve Moderna’s COVID-19 vaccine that targets both the original strain that kicked off the pandemic and a strain of the omicron variant.

For the health officials who steer vaccination campaigns, it’s going to be a complicated fall.